Word

CRST

Status

Pending

Status Code

638

Status Date

Friday, April 26, 2024

Serial Number

98201920

Mark Type

4

Filing Date

Thursday, September 28, 2023

Trademark Owner History

ReNAgade Therapeutics Management, Inc.

Classifications

5 Enzymes, nucleic acid molecules, and compounds/agents for modifying small RNAs with targeting agents for medical use, namely, use of the modified small RNAs in the gene editing industry; pharmaceutical preparations and therapeutic agents, namely, for gene therapy and mRNA regulation; pharmaceutical and biological preparations for medical use for the treatment of genetic and genomic disorders by gene therapy and mRNA regulation for use in human and animal therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders in humans and animals; pharmaceutical preparations for gene therapy and mRNA regulation

1 Chemical and biological agents for scientific and research use, namely, for the modification of small RNAs with targeting agents and for regulating expression and/or levels of mRNA with the modified RNAs; enzymes for scientific and research purposes; enzyme preparations for use in modifying small RNAs and for use of modified small RNAs in the gene editing industry; Nucleic acid sequences for other than medical and veterinary purposes

42 Research and development in the field of technology and engineering RNAs with targeting agents for use in gene therapy and mRNA regulation; development of new technology for others for enabling the engineering and modification of RNA with targeting agents, namely, developing molecular and cellular biology reagents, techniques, and assays for use in the gene editing industry

Trademark Events

Oct 2, 2023

New Application Entered

Oct 12, 2023

New Application Office Supplied Data Entered

Apr 26, 2024

Assigned To Examiner